Table 3 Odds ratio of developing HSP associated with vaccines
From: Henoch-Schönlein purpura and drug and vaccine use in childhood: a case-control study
Vaccine | Cases (288) | Controlsa (617) | Crude OR (95 % CI) | Adjusted ORb (95 % CI) |
|---|---|---|---|---|
MMR | 8 (2.8 %) | 6 (1 %) | 2.7 (0.8–9.7) | 3.4 (1.2–10.0) |
DTaP | 4 (1.4) | 6 (1 %) | 1.4 (0.3–6.1) | 2.0 (0.5–7.7) |
Any vaccine | 21 (7.3 %) | 68 (11 %) | 0.6 (0.4–1.1) | 0.9 (0.5–1.4) |